🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Spain / NCT07391189
Recruiting Not applicable

Healthy Effects of Adapted Aikido in People With Grip Disfunction

NCT07391189 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-01-19
Last updated
2026-02-13

Condition(s) studied

Unilateral Handgrip Dysfunction

Investigational drug(s) / intervention(s)

Participation in an adapted aikido program

Participation in an adapted aikido program: The aikido program has been adapted for optimal practice by people with handgrip dysfunction. Several key components of the techniques have been modified to enable their performance by individuals with limited hand mo- bility.

Study summary

This study investigates the effects of an adapted aikido exercise program on

the health of adults with unilateral wrist and/or hand dysfunction. The un- derlying assumption is that regular practice of adapted aikido may improve

physical, psychological, and quality-of-life parameters in this population com- pared with a non-exercising control group.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Be of legal age. * Have no prior knowledge of aikido. * Not be practicing other martial arts at the time of inclusion in the study or during the adapted training program. * Unilateral dysfunction of the hand and/or wrist that prevents or hinders tasks related to gripping (only for case group). Exclusion Criteria: * Presence of anatomical or functional alterations that could affect the performance of aikido techniques (other than those allowed for the study group). * Intellectual disability and/or inability to understand the informed con- sent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Catholic University of Murcia (UCAM) Murcia Murcia Recruiting

More Universidad Católica San Antonio de Murcia trials in Spain

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07391189 on ClinicalTrials.gov ↗ ← All trials in Spain